Medtronic (MDT) closed the most recent trading day at $78.10, moving +1.32% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.64%. On the other hand, the Dow registered a gain of 1.85%, and the technology-centric Nasdaq increased by 0.2%. The the stock of medical device company has fallen by 3.59% in the past month, lagging the Medical sector's gain of 0.71% and the S&P 500's gain of 3.82%. Market participants will be closely following the financial results of Medtronic in its upcoming release. The company plans to announce its earnings on August 20, 2024. The company is expected to report EPS of $1.20, unchanged from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $7.9 billion, showing a 2.54% escalation compared to the year-ago quarter. MDT's full-year Zacks Consensus Estimates are calling for earnings of $5.44 per share and revenue of $33.41 billion. These results would represent year-over-year changes of +4.62% and +3.22%, respectively. It is also important to note the recent changes to analyst estimates for Medtronic. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Medtronic is holding a Zacks Rank of #3 (Hold) right now. Investors should also note Medtronic's current valuation metrics, including its Forward P/E ratio of 14.16. For comparison, its industry has an average Forward P/E of 22.26, which means Medtronic is trading at a discount to the group. Meanwhile, MDT's PEG ratio is currently 2.25. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Products industry was having an average PEG ratio of 2.25. The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 157, positioning it in the bottom 38% of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow MDT in the coming trading sessions, be sure to utilize Zacks.com. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medtronic PLC (MDT):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...